Results 231 to 240 of about 13,289,951 (302)

Efficacy of epigallocatechin-3-gallate against oleic acid-induced acute respiratory distress syndrome.

Indian J Pharmacol
Panda SK, Sharma VGS, Sorathiya VL, Sahu PK.   +3 more
europepmc   +1 more source

Cardiopulmonary and Immune Alterations in the Ts65Dn Mouse Model of Down Syndrome and Modulation by Epigallocatechin-3-Gallate-Enriched Green Tea Extract. [PDF]

Pharmaceutics
Tielemans B, Llambrich S, Seldeslachts L, Cremer J, Tsui HC, Jonckheere AC, Marain NF, Riedel M, Wouters J, Herzen J, Leszczyński B, Verbeken E, Vanoirbeek J, Vande Velde G.   +13 more
europepmc   +1 more source

Fibril Synthesis From Food Processing By‐Products and Strategies for Structure–Function Stabilization for Food Applications

Sustainable Food Proteins, Volume 4, Issue 2, June 2026.
Protein fibrils can be synthesized from both conventional and by‐product protein sources, each having distinct advantages. Stabilization through polysaccharides and polyphenols can enhance fibril functional properties, such as gelling, foaming, and emulsification, thus furthering their application in food and non‐food materials.
Sanjana Sawant, Audrey L. Girard
wiley   +1 more source

Reduction of post-thawed sperm quality of Kacang goat using the addition of epigallocatechin-3-gallate into the skim milk-egg yolk extender. [PDF]

Open Vet J
Susilowati S, Mustofa I, Rosyada ZNA, Suprayogi TW, Hernawati T, Akintunde AO, Oktanella Y, Khairullah AR, Handayani UF, Ahmad RZ, Anggraini L, Pratama BP, Nugraha CD, Latifah L.   +13 more
europepmc   +1 more source

Cladostephus spongiosum as a Novel Protein Source: Bioactive, Techno‐Functional, and Physicochemical Properties

Journal of Food Science, Volume 91, Issue 6, June 2026.
ABSTRACT Recently, the food industry has been searching for alternative proteins, and macroalgaeare one of the novel protein sources. This study aimed to determine the optimum conditions for ultrasound‐ and enzyme‐assisted protein extraction from Cladostephus spongiosum (CS).
Aysun Yücetepe, Elif Feyza Aydar, Eda Şensu, Zehra Mertdinç, Aslı Can Karaça, Emine Şükran Okudan, Beraat Özçelik   +6 more
wiley   +1 more source

Unraveling the Effects of Epigallocatechin-3-gallate on Hepatocellular Carcinoma Cells: A Comparative Analysis of Monolayer vs Multicellular Tumor Spheroids. [PDF]

ACS Omega
Dos Reis Simpronio M, Machado ART, Santos P, Ribeiro DL, Antunes LMG, Aissa AF.   +5 more
europepmc   +1 more source

The Recruitment and Retention of Individuals With Intellectual Disability in Randomized Controlled Trials: A Scoping Review

British Journal of Learning Disabilities, Volume 54, Issue 2, Page 171-211, June 2026.
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody, Louise Murphy, Ruth Ryan, Rosemary Lyons, Wenyi Tang, Lorna Bourke   +5 more
wiley   +1 more source

Hydroxyproline-Modified Chitosan-Based Hydrogel Dressing Incorporated with Epigallocatechin-3-Gallate Promotes Wound Healing Through Immunomodulation. [PDF]

Gels
Ding P, Sun Y, Jiang G, Nie L.
europepmc   +1 more source

The Associations Between Dietary Flavonoid Intake and Neurodegenerative Diseases Risk: A Cross‐Sectional Study

Chemical Biology &Drug Design, Volume 107, Issue 6, June 2026.
Total flavonoid intake was significantly inversely associated with neurodegenerative diseases risk. Participants in the highest quartile (Q4) of total flavonoid intake exhibited a 48% lower risk compared to those in the lowest quartile (Q1) (OR = 0.52, 95% CI: 0.31–0.90; p for trend = 0.016).
Chenzhong Zong, Yang Dong, Xue Yu, Yu He, Xiaoqing Zhang, Kuo Gao   +5 more
wiley   +1 more source

(-)-Epigallocatechin-3-Gallate Suppresses Hyperexcitability in Rat Primary Nociceptive Neurons Innervating Inflamed Tissues: A Comparison with Lidocaine. [PDF]

Metabolites
Utugi S, Sashide Y, Takeda M.
europepmc   +1 more source